Turnstone Biologics Analyst Ratings
Turnstone Biologics Analyst Ratings
While ratings are subjective and will change, the latest Turnstone Biologics (TSBX) rating was a initiated with a price target of $0.00 to $20.00. The current price Turnstone Biologics (TSBX) is trading at is $11.73, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 70.5% | Piper Sandler | → $20 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/15/2023 | 70.5% | 派珀·桑德勒 | → 20 美元 | 啓動覆蓋開啓 | → 超重 |
What is the target price for Turnstone Biologics (TSBX)?
Turnstone Biologics（TSBX）的目標價格是多少？
The latest price target for Turnstone Biologics (NASDAQ: TSBX) was reported by Piper Sandler on August 15, 2023. The analyst firm set a price target for $20.00 expecting TSBX to rise to within 12 months (a possible 70.50% upside). 1 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年8月15日公佈了Turnstone Biologics（納斯達克股票代碼：TSBX）的最新目標股價。這家分析公司將目標股價定爲20.00美元，預計TSBX將在12個月內升至20.00美元（可能上漲70.50％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Turnstone Biologics (TSBX)?
分析師對Turnstone Biologics（TSBX）的最新評級是多少？
The latest analyst rating for Turnstone Biologics (NASDAQ: TSBX) was provided by Piper Sandler, and Turnstone Biologics initiated their overweight rating.
Turnstone Biologics（納斯達克股票代碼：TSBX）的最新分析師評級由派珀·桑德勒提供，Turnstone Biologics啓動了增持評級。
When is the next analyst rating going to be posted or updated for Turnstone Biologics (TSBX)?
Turnstone Biologics（TSBX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Turnstone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Turnstone Biologics was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析師在進行了廣泛的研究，包括瀏覽公開財務報表、與Turnstone Biologics的高管和客戶交談以及聽取業績電話會議後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Turnstone Biologics的最後一次評級是在2023年8月15日提交的，因此你應該預計下一個評級將在2024年8月15日左右公佈。
Is the Analyst Rating Turnstone Biologics (TSBX) correct?
分析師對Turnstone Biologics（TSBX）的評級正確嗎？
While ratings are subjective and will change, the latest Turnstone Biologics (TSBX) rating was a initiated with a price target of $0.00 to $20.00. The current price Turnstone Biologics (TSBX) is trading at is $11.73, which is within the analyst's predicted range.
儘管評級是主觀的，會發生變化，但最新的Turnstone Biologics（TSBX）評級是最初的，目標股價爲0.00美元至20.00美元。Turnstone Biologics（TSBX）目前的交易價格爲11.73美元，在分析師的預測區間內。
